Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alexza Pharmaceutica (ALXA)

Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alexza Pharmaceutica 2091 STIERLIN COURT MOUNTAIN VIEW CA 94043

www.alexza.com P: 650-944-7000

Description:

Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

Key Statistics

Overview:

Market Capitalization, $K 20,340
Shares Outstanding, K 21,750
Annual Sales, $ 5,030 K
Annual Net Income, $ -21,310 K
Last Quarter Sales, $ 720 K
Last Quarter Net Income, $ -3,360 K
60-Month Beta 0.75
% of Insider Shareholders 3.70%
% of Institutional Shareholders 14.21%

Growth:

1-Year Return -20.63%
3-Year Return -76.96%
5-Year Return -94.62%
5-Year Revenue Growth -88.27%
5-Year Earnings Growth -1,330.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 08/04/16
Earnings Per Share ttm -1.81
EPS Growth vs. Prev Qtr 45.76%
EPS Growth vs. Prev Year 57.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 06/13/12

ALXA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -174.04%
Profit Margin % -423.66%
Debt/Equity -0.29
Price/Sales 4.05
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -3.42
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar